Prophylactic neck dissection for low-risk differentiated thyroid cancers: Risk-benefit analysis

被引:7
|
作者
Dubernard, Xavier [1 ,2 ]
Dabakuyo, Sandrine [1 ]
Ouedraogo, Samiratou [1 ]
Amroun, Koceila [3 ]
Kere, David [3 ]
Nasser, Talal [4 ]
Deguelte, Sophie [5 ]
Pochart, Jean-Marie [1 ]
Merol, Jean-Claude [2 ]
Makeieff, Marc [2 ]
Chays, Andre [2 ]
Schvartz, Claire [1 ]
机构
[1] CLCC Inst Jean Godinot, Thyroide Marne Ardennes Register, Reims, France
[2] Ctr Hosp Robert Debre, Dept Otolaryngol, Rue Gen Koenig, F-51100 Reims, France
[3] CLCC Inst Jean Godinot, Dept Gen Surg, Reims, France
[4] Polyclin Courlancy, Dept Otolaryngol, Reims, France
[5] Ctr Hosp Robert Debre, Dept Gen Surg, Reims, France
关键词
prophylactic; dissection; low-risk; thyroid; cancers; POSTOPERATIVE THYROGLOBULIN LEVELS; RECURRENT LARYNGEAL NERVES; LYMPH-NODE METASTASES; PARATHYROID REOPERATIONS; CARCINOMA; PAPILLARY; IMPACT; MORBIDITY; SURVIVAL; PATTERN;
D O I
10.1002/hed.24402
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. The benefit of neck dissection is the subject of debate in differentiated thyroid cancer (DTC). We analyze the risk-benefit of neck dissection for low-risk DTC without detectable lymph nodes. Methods. We conducted a retrospective study from 1983 to 2003; which included 295 patients without detectable lymph nodes who were treated by thyroidectomy with (C+) or without (C-) neck dissection. All patients had iodine131 therapy. We compared the frequency of remission, disease progression, and permanent complications between groups. Results. Two hundred twelve patients comprised the C1 group, and 83 patients the C-group. Respectively for C1 versus C-, remission rates were 92% versus 89.2% (p=.40), and progressive disease observed was 3.3% versus 7.2% (p=.10). Permanent hypoparathyroidism occurred in 15.1% in C+ versus 3.6% in C-(p=.006). Conclusion. The risk-benefit analysis of neck dissection in patients with low-risk DTC shows no benefit in terms of complete remission or occurrence of progression. However, risk of complications seems to be higher in patients with neck dissection. (C) 2016 Wiley Periodicals, Inc.
引用
收藏
页码:1091 / 1096
页数:6
相关论文
共 50 条
  • [41] Prophylactic Central Neck Dissection in Differentiated Thyroid Cancer: An Assessment of the Evidence
    David E. Gyorki
    Brian Untch
    R. Michael Tuttle
    Ashok R. Shaha
    Annals of Surgical Oncology, 2013, 20 : 2285 - 2289
  • [42] Prophylactic Central Neck Lymph Node Dissection in Low-risk Thyroid Carcinoma Patients Does Not Decrease the Incidence of Locoregional Recurrence A Meta-analysis of Randomized Trials
    Sanabria, Alvaro
    Betancourt, Carlos
    Sanchez, Juan G.
    Garcia, Carlos
    ANNALS OF SURGERY, 2022, 276 (01) : 66 - 73
  • [43] Prophylactic central lymph node dissection for low-risk papillary thyroid cancer-Impact on subsequent therapy
    Ren, Tianrui
    Min, Seojung
    Grodski, Simon
    Serpell, Jonathan
    Lee, James C.
    WORLD JOURNAL OF SURGERY, 2025, 49 (01) : 170 - 178
  • [44] QUANTIFYING BENEFIT-RISK TRADEOFFS FOR SURGICAL OPTIONS IN LOW-RISK THYROID CANCER
    Ahmadi, S.
    Talbott, M.
    Reed, S.
    Sepulveda, Gonzalez J. M.
    Yang, J. C.
    Scheri, R.
    Stang, M.
    Roman, S.
    Sosa, J. A.
    VALUE IN HEALTH, 2019, 22 : S372 - S372
  • [45] Risk of needing completion thyroidectomy for low-risk papillary thyroid cancers treated by lobectomy
    DiMarco, A. N.
    Wong, M. S.
    Jayasekara, J.
    Cole-Clark, D.
    Aniss, A.
    Glover, A. R.
    Delbridge, L. W.
    Sywak, M. S.
    Sidhu, S. B.
    BJS OPEN, 2019, 3 (03): : 299 - 304
  • [46] Comparison of surgical strategies in the treatment of low-risk differentiated thyroid cancer
    András Kiss
    Balázs Szili
    Bence Bakos
    Richárd Ármós
    Zsuzsanna Putz
    Kristóf Árvai
    Barbara Kocsis-Deák
    Bálint Tobiás
    Bernadett Balla
    Henriett Pikó
    Magdolna Dank
    János Pál Kósa
    István Takács
    Péter Lakatos
    BMC Endocrine Disorders, 23
  • [47] Total or partial thyroidectomy for low-risk differentiated thyroid cancer: that is the question!
    Rugiu, Maria Gabriella
    Miani, Cesare
    Locatello, Luca Giovanni
    ACTA OTORHINOLARYNGOLOGICA ITALICA, 2022, 42 (05) : 487 - 489
  • [48] Role of 131I in low-risk differentiated thyroid cancer
    Vallejo, J. A.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (01): : 33 - 37
  • [49] The Landmark Series: Extent of Surgery for Low-Risk Differentiated Thyroid Cancer
    Ullmann, Timothy M.
    Sosa, Julie A.
    ANNALS OF SURGICAL ONCOLOGY, 2025,
  • [50] Comparison of surgical strategies in the treatment of low-risk differentiated thyroid cancer
    Kiss, Andras
    Szili, Balazs
    Bakos, Bence
    armos, Richard
    Putz, Zsuzsanna
    arvai, Kristof
    Kocsis-Deak, Barbara
    Tobias, Balint
    Balla, Bernadett
    Piko, Henriett
    Dank, Magdolna
    Kosa, Janos Pal
    Takacs, Istvan
    Lakatos, Peter
    BMC ENDOCRINE DISORDERS, 2023, 23 (01)